These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12578227)

  • 1. Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy.
    Zemaitaitis MO; Kim SY; Halverson RA; Troncoso JC; Lee JM; Muma NA
    J Neuropathol Exp Neurol; 2003 Feb; 62(2):173-84. PubMed ID: 12578227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy.
    Zemaitaitis MO; Lee JM; Troncoso JC; Muma NA
    J Neuropathol Exp Neurol; 2000 Nov; 59(11):983-9. PubMed ID: 11089576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
    Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
    Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration.
    Takanashi M; Mori H; Arima K; Mizuno Y; Hattori N
    Brain Res Mol Brain Res; 2002 Aug; 104(2):210-9. PubMed ID: 12225876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
    Borghi R; Giliberto L; Assini A; Delacourte A; Perry G; Smith MA; Strocchi P; Zaccheo D; Tabaton M
    Neurology; 2002 Feb; 58(4):589-92. PubMed ID: 11865137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.
    Ebashi M; Ito Y; Uematsu M; Nakamura A; Hirokawa K; Kamei S; Uchihara T
    Acta Neuropathol Commun; 2019 May; 7(1):71. PubMed ID: 31060611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease.
    Chambers CB; Lee JM; Troncoso JC; Reich S; Muma NA
    Ann Neurol; 1999 Sep; 46(3):325-32. PubMed ID: 10482263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA.
    Levy R; Ruberg M; Herrero MT; Villares J; Javoy-Agid F; Agid Y; Hirsch EC
    Neurology; 1995 Jan; 45(1):127-34. PubMed ID: 7824102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcortical
    Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can secondary degeneration accelerate the formation of neurofibrillary tangles? A case of hemispheric infarction showing asymmetric degeneration of the substantia nigra, red nuclei, inferior olivary nuclei and dentate nuclei with concomitant changes of progressive supranuclear palsy.
    Matsumoto R; Oda M; Arai N; Shin T; Hayashi M
    Acta Neuropathol; 1999 Feb; 97(2):208-14. PubMed ID: 9928834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibrillary tangles in progressive supranuclear palsy brains exhibit immunoreactivity to frameshift mutant ubiquitin-B protein.
    Fergusson J; Landon M; Lowe J; Ward L; van Leeuwen FW; Mayer RJ
    Neurosci Lett; 2000 Jan; 279(2):69-72. PubMed ID: 10674623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive supranuclear palsy presenting with primary progressive aphasia--clinicopathological report of an autopsy case.
    Mochizuki A; Ueda Y; Komatsuzaki Y; Tsuchiya K; Arai T; Shoji S
    Acta Neuropathol; 2003 Jun; 105(6):610-4. PubMed ID: 12669238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.
    Wilhelmus MM; de Jager M; Rozemuller AJ; Brevé J; Bol JG; Eckert RL; Drukarch B
    J Pathol; 2012 Jan; 226(1):132-42. PubMed ID: 22009441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
    Halverson RA; Lewis J; Frausto S; Hutton M; Muma NA
    J Neurosci; 2005 Feb; 25(5):1226-33. PubMed ID: 15689560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive supranuclear palsy.
    Tawana K; Ramsden DB
    Mol Pathol; 2001 Dec; 54(6):427-34. PubMed ID: 11724919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in tau isoform expression in different brain regions and disease states.
    Majounie E; Cross W; Newsway V; Dillman A; Vandrovcova J; Morris CM; Nalls MA; Ferrucci L; Owen MJ; O'Donovan MC; Cookson MR; Singleton AB; de Silva R; Morris HR
    Neurobiol Aging; 2013 Jul; 34(7):1922.e7-1922.e12. PubMed ID: 23428180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
    Togo T; Dickson DW
    Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy.
    Katsuse O; Dickson DW
    Acta Neuropathol; 2004 Aug; 108(2):143-6. PubMed ID: 15235807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.